{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial Comparing No-Touch and Conventional Techniques for Autogenous Arteriovenous Fistula Creation"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation methods and allocation concealment were reported in two RCTs, with one using envelopes."
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "comparing conventional and no-touch techniques for AVF creation"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the primary patency rate from 6 months to 2 years."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation methods and allocation concealment were reported in two RCTs, with one using envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not reported."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 699 patients were included, with 360 in the conventional group and 339 in the no-touch group."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The primary patency rate was significantly higher in the no-touch group (OR 0.46, 95% CI 0.31\u20130.68; P < 0.0001)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Adverse events were not reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration and funding sources were not reported."
      },
      "Funding": {
        "score": 0,
        "evidence": "Trial registration and funding sources were not reported."
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}